Medicure (MCUJF) Change in Intangibles (2009 - 2024)
Medicure's (MCUJF) quarterly Change in Intangibles came in at -$320700.4 in Q4 2024, down 241.1% year-on-year from $227292.2 in Q1 2024, and down 337.49% quarter-over-quarter from -$73305.3 in Q3 2024.
Medicure (MCUJF) Change in Intangibles (2009 - 2024) Analysis & Trends
Medicure's Change in Intangibles history runs 12 years deep, the most recent figure standing at -$320700.4 for Q4 2024.
- On a quarterly basis, Change in Intangibles fell 241.1% year-over-year to -$320700.4 in Q4 2024; TTM through Mar 2025 was -$470044.4, a 92.35% decrease from a year earlier, with the FY2024 full-year figure at -$539765.2, down 169.73% from the prior year.
- Change in Intangibles declined to -$320700.4 in Q4 2024 per MCUJF's latest filing, from -$73305.3 in the prior quarter.
- Across five years, Change in Intangibles topped out at -$19971.8 in Q1 2023 and bottomed at -$320700.4 in Q4 2024.
- The 4-year median for Change in Intangibles is -$85782.0 (2023), against an average of -$121743.3.
- Across the five-year window, Change in Intangibles jumped 58.41% in 2023 and plunged 241.1% in 2024, its largest moves.
- Year by year, Change in Intangibles stood at -$235939.6 in 2021, then advanced by 12.58% to -$206254.7 in 2022, then soared by 54.42% to -$94020.5 in 2023, then plunged by 241.1% to -$320700.4 in 2024.
- Per Business Quant, the three latest MCUJF Change in Intangibles figures stand at -$320700.4 (Q4 2024), -$73305.3 (Q3 2024), and -$76038.6 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -320,700.41 |
| Dec 31, 2024 | -320,700.41 |
| Sep 30, 2024 | -73,305.34 |
| Sep 30, 2024 | -73,305.34 |
| Jun 30, 2024 | -76,038.62 |
| Jun 30, 2024 | -76,038.62 |
| Mar 31, 2024 | -64,563.85 |
| Mar 31, 2024 | -64,563.85 |
| Dec 31, 2023 | -94,020.55 |
| Dec 31, 2023 | -94,020.55 |
| Sep 30, 2023 | -85,782.00 |
| Sep 30, 2023 | -85,782.00 |
| Mar 31, 2023 | -19,971.80 |
| Mar 31, 2023 | -19,971.80 |
| Sep 30, 2022 | -206,254.74 |
| Sep 30, 2022 | -206,254.74 |
| Jun 30, 2022 | -125,494.50 |
| Jun 30, 2022 | -125,494.50 |
| Mar 31, 2022 | -37,105.34 |
| Mar 31, 2022 | -37,105.34 |